Oral Microbiome Changes During Pregnancy: Clinical Implications and Recent Insights

Abstract

Pregnancy induces dynamic physiological and immunological changes that significantly alter the composition and function of the oral microbiome. These changes may impact maternal oral and systemic health as well as pregnancy outcomes. This review synthesizes current evidence on oral microbiome alterations during pregnancy, elucidating epidemiology, underlying mechanisms, risk factors, clinical manifestations, diagnostic approaches, management strategies, emerging therapies, and guideline-based recommendations, with a focus on clinical relevance for healthcare professionals.

Introduction

Pregnancy is characterized by complex hormonal, metabolic, and immunological shifts that influence multiple body systems, including the oral cavity. The oral microbiome, traditionally considered stable, demonstrates notable alterations in composition and diversity during pregnancy. These modifications are increasingly recognized for their role in oral diseases, such as gingivitis and periodontitis, and their potential impact on adverse pregnancy outcomes including preterm birth and low birth weight. Understanding these changes is essential for optimizing maternal and fetal health.

Epidemiology / Disease Burden

Globally, approximately 60–75% of pregnant individuals exhibit some degree of gingival inflammation, with pregnancy-associated gingivitis being the most common oral complication. Epidemiological studies indicate a higher prevalence of periodontitis in pregnant women compared to non-pregnant controls, likely mediated by microbiome shifts. The disease burden is particularly high in regions with limited access to dental care and oral health education, further underscoring the need for integrated prenatal and oral healthcare services.

Pathophysiology

The pathophysiological basis for oral microbiome alterations during pregnancy is multifactorial. Elevated levels of estrogen and progesterone modulate the oral mucosa, alter salivary composition, and influence immune responses. These hormonal changes facilitate the growth of specific microbial taxa, such as Prevotella intermedia, Fusobacterium nucleatum, and Porphyromonas gingivalis, while reducing overall microbial diversity. The resulting dysbiosis promotes a pro-inflammatory environment, exacerbating susceptibility to gingival and periodontal diseases. Furthermore, systemic inflammatory mediators produced in response to oral pathogens may translocate to the placenta, contributing to adverse pregnancy outcomes.

Risk Factors

Key risk factors for unfavorable oral microbiome changes in pregnancy include poor pre-existing oral hygiene, limited access to dental care, high dietary sugar intake, smoking, gestational diabetes, and socio-economic barriers. Genetic predisposition, underlying periodontal disease, and immunosuppressive conditions further amplify risk. Recent research also suggests that maternal stress, altered salivary flow, and specific ethnic or geographical backgrounds may influence the oral microbiota during pregnancy.

Clinical Features

Pregnancy-associated oral microbiome changes manifest most commonly as gingival inflammation, with clinical features including erythema, edema, bleeding on probing, and in some cases, pyogenic granuloma (pregnancy tumor). Periodontal pockets may deepen, and attachment loss can occur, particularly in those with pre-existing periodontal disease. Halitosis, increased dental caries, and oral mucosal lesions have also been reported. Notably, these changes often peak during the second and third trimesters and may resolve postpartum, although some individuals may experience persistent oral health challenges.

Diagnosis

Diagnosis is primarily clinical, based on a comprehensive oral examination noting gingival and periodontal status. Periodontal indices, probing depth measurements, and bleeding scores are essential for assessment. Recent advances in molecular diagnostics, such as 16S rRNA sequencing and metagenomic analyses, enable detailed characterization of the oral microbiome and identification of dysbiotic shifts. Salivary biomarkers, including inflammatory cytokines and microbial metabolites, are emerging as adjunctive diagnostic tools to monitor disease progression and therapeutic response in pregnant patients.

Treatment & Management

Management of oral microbiome changes during pregnancy centers on preventive care, meticulous oral hygiene, and targeted therapeutic interventions. Professional dental cleaning, scaling, and root planing are safe and effective throughout pregnancy, ideally performed during the second trimester. Antimicrobial mouth rinses (e.g., chlorhexidine) may be used with caution. Patient education on oral hygiene, nutritional counseling, and cessation of tobacco use are critical components. In cases of established periodontitis or persistent lesions, collaboration with obstetricians and periodontists is essential to tailor treatment and mitigate systemic risks.

Recent Advances / Emerging Therapies

Recent research highlights the potential of probiotics and prebiotics to modulate the oral microbiome favorably during pregnancy. Clinical trials evaluating the use of Lactobacillus-containing lozenges and oral supplements have demonstrated reductions in gingival inflammation and pathogenic bacterial load. Advances in metagenomic sequencing allow personalized risk stratification and targeted interventions. Furthermore, salivary diagnostics and chairside rapid tests are increasingly accessible, facilitating early detection and monitoring of oral health changes in pregnant individuals. Ongoing studies are exploring the role of microbiome transplantation and next-generation antimicrobials for refractory cases.

Guideline Recommendations

Major dental and obstetric associations, including the American College of Obstetricians and Gynecologists (ACOG) and the American Dental Association (ADA), recommend routine dental evaluation and necessary treatment during pregnancy. Guidelines emphasize the importance of interprofessional collaboration, patient education, and risk assessment. Pregnant individuals should receive counseling regarding the safety of dental procedures and the importance of maintaining oral health to prevent adverse pregnancy outcomes. Emerging consensus supports the integration of oral health into prenatal care protocols, with particular attention to high-risk groups.

Conclusion

Oral microbiome changes during pregnancy represent a clinically significant phenomenon with implications for both maternal and fetal health. Recognition and management of these changes require a multidisciplinary approach, incorporating current evidence, patient education, and proactive preventive care. Ongoing research into the mechanisms, diagnostics, and therapeutic interventions for pregnancy-associated oral microbiome shifts holds promise for improving outcomes and advancing personalized care in maternal oral health.